摘要
目的:探讨血小板和红细胞磷脂酰丝氨酸(PS)暴露和循环微粒(MPs)在脓毒症高凝状态中的作用。方法:集10例诊断为脓毒症的患者及10例健康体检者的新鲜血;离心分离出红细胞、富血小板血浆及MPs;应用Alexa-Fluro 488-乳粘素/CD 41a/CD14、Alexa-Fluro 647-CD 235a/CD 31/CD 45标定红细胞、血小板、内皮细胞、白细胞及单核细胞来源的MPs;流式细胞仪测定红细胞和血小板的PS外翻、MPs的数量;血凝仪测定相应凝血时间。结果:相对于健康人,脓毒症患者PS外翻红细胞(3.53%vs0.53%,P<0.05)和血小板(3.00%vs 0.45%,P<0.05)、MPs总数(4830/μL vs 2861/μL,P<0.05)及各亚型MPs均明显升高;红细胞(238.4s vs 346.8s,P<0.05)、血小板(209.1s vs 335.9s,P<0.05)及MPs(207.1s vs 318.2s,P<0.05)的凝血时间缩短。MP数、PS+红细胞/血小板比例分别与各自凝血时间成负相关(MP:r=-0.592,P=0.006;红细胞:r=-0.565,P=0.009;血小板:r=-0.641,P=0.002)。结论:红细胞、血小板的PS暴露及循环MPs和脓毒症高凝状态的发生相关,可能对患者凝血功能检测和抗凝治疗有一定的意义。
Objective: To investigate the role of microparticle (MP) and phosphatidylserine (PS) exposure of erythrocytes and platelets in the procoagulant state in sepsis. Methods: Peripheral blood samples were collected from 10 patients with newly diagnosed sepsis and 10 matched healthy subjects. Erythrocytes, platelets, and MPs were obtained by centrifugation. Alexa-Fluro 488-1actadherin/CD 41a/CD 14 and Alexa-Fluro 647-CD 235a/CD 31/CD 45 were used to label MPs derived from platelets, monocytes, erythrocytes, endothelial cells, and leukocytes. PS exposure of platelets and erythrocytes was detected with Alexa-Fluro 488-1actadherin. Analysis of MP release and PS exposure on erythrocytes and platelets were performed with a flow cytometer. Procoagulant activity (PCA) was determined by clotting time. Results: Compared with healthy subjects, patients with sepsis had markedly increased MP release (4830/μLvs 2861/μL, P〈0.05) and PS exposure on erythrocytes (3.53% vs 0.53%, P〈0.05) and platelets (3.00% vs 0.45%, P〈0.05). Relevant PCA was significantly increased as determined by shortened clotting time (erythrocytes: 238.4s vs 346.8s, P〈0.05; platelets: 209. l s vs 335.9s, P〈0.05; MPs: 207.1s vs 318.2s, P〈0.05). The level of circulating MPs, PS+ erythrocytes %, and PS+ platelets% was negatively correlated with its own relevant clotting time (MP: r= -0.592, P=0.006; erythrocytes: r= -0.565, P=0.009; platelets: r= -0.641, P=0.002). Conclusions: Increased MPs and PS+ erythrocytes/platelets are associated with the procoagulant state in patients with sepsis, and may have clinical significance in evaluating and predicting the effect of anticoagnlant therapy.
出处
《现代生物医学进展》
CAS
2014年第26期5049-5053,共5页
Progress in Modern Biomedicine
关键词
磷脂酰丝氨酸
微粒
脓毒症
凝血
Phosphatidylserine
Microparticle
Sepsis
Coagulation